J&J ‘very confident’ in vaccine, eyes quick resolution

Johnson & Johnson remains “very confident” in its COVID-19 vaccine and hopeful for a quick resolution from regulators over its status, a top executive said Tuesday. “We remain very confident and very hopeful that the benefit-risk profile will play out,” J&J Chief Financial Officer Joseph Wolk told CNBC. The comments…

New treatment for dry eye in sight

A new, enzyme-based treatment for extremely dry eyes resulted in an early clinical study of an improvement of the complaints. The new treatment could fill a gap as there are currently only two active ingredients against dry eyes, which are not tolerated by all Concerned. Eye drops containing an enzyme…